Jordan Conducts Airstrikes on Suspected Iranian-Backed Drug Smugglers in Syria
In a significant move, Jordan conducted air strikes within Syria on Thursday, targeting suspected warehouses and hideouts believed to be operated by Iranian-backed... Read more.
Merck Explores Broader Health Benefits Beyond Weight Loss in GLP-1 Treatments
Merck & Co (MRK.N) is exploring GLP-1 treatments that offer benefits beyond weight loss, according to CEO Robert Davis. GLP-1 class drugs, such as Novo Nordisk’s... Read more.
Elevance Health Set For Strategic Acquisition of Paragon Healthcare for Over $1 Billion
Elevance Health (ELV.N) is set to acquire private firm Paragon Healthcare for a sum exceeding $1 billion, according to sources cited by Axios on January 4. Earlier... Read more.
Dr. John N. van den Anker Assumes Role of Editor-in-Chief for The Journal of Clinical Pharmacology
The American College of Clinical Pharmacology (ACCP) has announced the appointment of Dr. John N. van den Anker, MD, PhD, FAAP, FCP, as the new Editor-in-Chief of... Read more.
CVS Pharmacy Unveils Enhanced Loyalty Program for Simplified Member Experience
CVS Pharmacy, the retail arm of CVS Health® (NYSE: CVS), has announced a comprehensive upgrade to its loyalty program, introducing two membership tiers: ExtraCare®... Read more.
Fusion Pharmaceuticals Announces Clinical Program and Manufacturing Updates
Fusion Pharmaceuticals, a clinical-stage oncology company specializing in next-generation radiopharmaceuticals as precision medicines, shared significant advancements... Read more.
Global IVD Procedure Volumes 2023-2028: IVD Tests by Region, Countries, and Worldwide Cost
Research and Markets recently launched the “In Vitro Diagnostic (IVD) Procedure Volumes (Chemistry, Immunoassays, Hematology, Microbiology, Histology, Point... Read more.
Nanoform’s Breakthrough: Game-Changing Prostate Cancer Pill Promises Daily Dose Revolution
Nanoform, the medicine performance-enhancing company based in Helsinki, Finland, has initiated a trial to assess the relative bioavailability of its nanocrystalline... Read more.
FDA Warns Health Care Providers And Patients Not to Use Synovo Total Hip Resurfacing System
The U.S. Food and Drug Administration (FDA) has issued a safety communication warning healthcare providers and patients to avoid using the Synovo Total Hip Resurfacing... Read more.
BridGene Biosciences and Galapagos NV Join Forces in Landmark Collaboration for Oncology Drug Discovery
BridGene Biosciences, Inc., a trailblazer in small molecule drug discovery for challenging targets, has announced a strategic collaboration and licensing agreement... Read more.